6 completed, 1 active not recruiting, 1 unknown. 8 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Active not recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow FHI 360: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Casea S Contraceptive Implants (Casea S) Trial 22.2 mg Etonogestrel (ENG), 44.4 mg Etonogestrel (ENG) - Contraception | Phase 1 | Active not recruiting | FHI 360 | 20 | 2023-12-13 | 2026-04-08 |
| A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age TV-46046, Depo-subQ Provera - Contraception | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 60 | 2020-12-14 | 2024-02-26 |
| A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046 TV-46046, Depo-subQ 104, TV-46046 Placebo - Contraception | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 27 | 2019-01-15 | 2022-01-26 |
| Lower Dose Depo Provera® Contraceptive Injection Depo-Provera CI, Depo-subQ 104 - Contraception | Phase 1 | Completed | FHI 360 | 60 | 2016-12-02 | 2018-06-14 |
| Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle TV-46046 - 400 mg/mL, TV-46046 - 200 mg/mL - Pregnancy, Contraception | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 12 | 2016-10-26 | 2024-02-12 |
| Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods DMPA 150, DMPA 300, DMPA 104 - Contraception | Phase 1 | Completed | FHI 360 | 42 | 2015-09-01 | 2018-10-18 |
| Male Circumcision (MC) Using the ShangRing™ Device in Malawi ShangRing - Male Circumcision | Phase 1 | Completed | FHI 360 | 500 | 2015-06-01 | 2016-01-21 |
| Community Intervention to Prevent Nipah Spillover Ask people not to drink raw sap, Ask people not to drink sap or drink sap from skirt protected trees, No Intervention - Human NiV Infection | Phase 1 / Phase 2 | Unknown | International Centre for Diarrhoeal Disease Research, Bangladesh | 7782 | 2012-11-10 | 2021-05-25 |
Medroxyprogesterone Acetate (4) · Injections, Intramuscular (1) · etonogestrel (1)
Dominican Republic (5) · United States (3) · Bangladesh (1) · Brazil (1) · Chile (1) · Malawi (1)
Vera Halpern, MD (2) · Kavita Nanda, M.D. (1) · Paul Feldblum, Ph.D. (1)